Company news
HCW Biologics Inc. news in 2021
HCW Biologics Inc.'s news releases, calls and decks from 2021, newest first.
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
December 12, 2021
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
November 11, 2021
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer
October 27, 2021
HCW Biologics Announces Appointment of Two New Members to Board of Directors
October 26, 2021
HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic
August 23, 2021
HCW Biologics’ Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI™) Discovery Platform
August 16, 2021
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
August 12, 2021
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
July 21, 2021
HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering
July 18, 2021
Decks in 2021
- IPO Roadshow (July 2021)
IPO roadshow · 12 slides · Jul 12, 2021